John Charles Morris MD
Professor of Medicine, Co-Director, Comprehensive Lung Cancer Center, Associate Director, UCCI Translational Research and Director, Experimental Therapeutics
Join to View Full Profile
3199 Highland AveCincinnati, OH 45219
Phone+1 513-584-6928
Fax+1 513-584-4281
Dr. Morris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NIH Clinical CenterPost-Doctoral Fellowship, 1995 - 1999
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1986 - 1988- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalChief Residency, Internal Medicine, 1985 - 1986
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1982 - 1985
SUNY Upstate Medical UniversityClass of 1982
Certifications & Licensure
NY State Medical License 1983 - 2024
OH State Medical License 2010 - 2022
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Corticolimbic Degeneration and Treatment of Dementia Start of enrollment: 2004 Nov 01
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- 2 citationsA Phase I Trial to Determine the Safety and Tolerability of Autophagy Inhibition Using Chloroquine or Hydroxychloroquine in Combination with Carboplatin and Gemcitabin...Nagla Abdel Karim, Ihab Eldessouki, Imran Ahmed, Ola Gaber, Elmustapha Bahassi
Asian Pacific Journal of Cancer Prevention. 2025-04-01 - 4 citationsA Phase I Study of the Non-Receptor Kinase Inhibitor Bosutinib in Combination with Pemetrexed in Patients with Selected Metastatic Solid Tumors.Nagla Abdel Karim, Asad Ullah, Hongkun Wang, Mahran Shoukier, Steven Pulliam
Current Oncology. 2022-12-03 - 1 citationsDoes Molecular Profiling of-Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?Nagla Abdel Karim, Asad Ullah, Peterson Pathrose, Hassana Fathallah, Ashley Perry
Current Oncology. 2022-07-07
Press Mentions
A Progress Report: Expanding Palliative Care with Project ECHOFebruary 19th, 2019
More Non-Smokers Being Diagnosed with Lung CancerNovember 9th, 2018
Recent Studies Unveil Clues to Using Immunotherapy as Cancer TreatmentJuly 3rd, 2018
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
